QT Imaging Holdings, Inc. (NASDAQ:QTI – Get Free Report) was the recipient of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 233,079 shares, a decrease of 53.0% from the May 14th total of 495,661 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 54,372 shares, the days-to-cover ratio is presently 4.3 days.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on QTI. Zacks Research raised shares of QT Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Wall Street Zen raised shares of QT Imaging to a “hold” rating in a research note on Saturday, May 16th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.
Read Our Latest Stock Analysis on QTI
QT Imaging Price Performance
QT Imaging (NASDAQ:QTI – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.11). QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. The company had revenue of $6.53 million for the quarter, compared to the consensus estimate of $6.45 million. As a group, equities analysts expect that QT Imaging will post -0.59 earnings per share for the current fiscal year.
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Featured Stories
- Five stocks we like better than QT Imaging
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
